The Patent Finder

Ureka SARL

Also on record
Records under this name other than the patents Ureka SARL holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Ureka SARL

PatentTitleStatus Expires Confidence
US 10,889,627Pro-drug peptide with improved pharmaceutical properties
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,691,807New Hybrid Oligomers, Their Preparation Process and Pharmaceutical Compositions Containing Them
Term ended
Ended no later than Mar 17, 2026 · Medium confidence
Term endedEnded no later than Mar 17, 2026Medium confidence
US 11,267,861Peptide-oligourea foldamer compounds and methods of their use
Lapsed on the fee record
Ended Mar 8, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 8, 2026From the USPTO record
US 8,138,145Hybrid Oligomers, Their Preparation Process and Pharmaceutical Compositions Containing Them
Formerly held
Lapsed on the fee record
Ended Mar 20, 2024 · Medium confidence
Lapsed on the fee recordEnded Mar 20, 2024Medium confidence
US 10,414,722Bioinspired Catalysis Using Oligourea Helical Foldamers
Lapsed on the fee record
Ended Sep 17, 2023 · High confidence
Lapsed on the fee recordEnded Sep 17, 2023High confidence
US 10,233,213Foldamer Helix Bundle-Based Molecular Encapsulation
Lapsed on the fee record
Ended Mar 19, 2023 · High confidence
Lapsed on the fee recordEnded Mar 19, 2023High confidence
US 7,777,030Compositions and Methods for the Treatment and Prevention of Disease
Lapsed on the fee record
Ended Aug 17, 2022 · High confidence
Lapsed on the fee recordEnded Aug 17, 2022High confidence
US 7,671,029Compositions and methods for enhanced pharmacological activity of compositions comprising peptide drug substances
Term ended
Term ended Feb 23, 2022 · From the USPTO record
Term endedTerm ended Feb 23, 2022From the USPTO record
US 6,908,900Compositions and Methods for Enhanced Pharmacological Activity Through Oral and Parenteral Administration of Compositions Comprising Polypeptide Drug Substances and Other Poorly Absorbed Active Ingredients
Term ended
Term ended Feb 19, 2022 · From the USPTO record
Term endedTerm ended Feb 19, 2022From the USPTO record
US 7,186,828Cyclic Urea Compounds and Preparation Thereof
Term ended
Term ended Jan 19, 2022 · High confidence
Term endedTerm ended Jan 19, 2022High confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited